Analyst Ratings for Inhibikase Therapeutics Inc (IKT)
IKT Rating Summary
IKT Price Target Summary
- Highest: $8.00 (H.C. Wainwright)
- Lowest: $1.50 (Chardan)
- Average: $5.21
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$5.21 (+216%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
Avg. $ Target:
$5.21 (+216%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2026 | Chardan | Andreas Argyrides | New Coverage | Neutral (N/A) |
1.50 (N/A) |
1.97 (1.65) |
-16.24% | Details |
| 6/10/2026 | Oppenheimer | Mazahir Alimohamed | New Coverage | Outperform (N/A) |
5.00 (N/A) |
1.67 (1.65) |
-1.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
